Education
About Us
Working with TipRanks
Follow Us
Relmada Therapeutics (RLMD)
NASDAQ:RLMD
See the Price Targets and Ratings of:
RLMD Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Mizuho Securities
$1
Hold
-39.76%
Downside
Reiterated
06/12/25
Leerink Partners
―
Hold
―
Reiterated
05/13/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Mizuho Securities
$1
Hold
-39.76%
Downside
Reiterated
06/12/25
Leerink Partners
―
Hold
―
Reiterated
05/13/25
Best Analysts Covering Relmada Therapeutics
1 Month
xxx
Success Rate
2/4 ratings generated profit
Average Return
-1.05%
upgraded a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -1.05% per trade.
3 Months
xxx
Success Rate
1/4 ratings generated profit
Average Return
-25.30%
upgraded a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of -25.30% per trade.
1 Year
Success Rate
1/4 ratings generated profit
Average Return
-30.80%
upgraded a buy rating a year ago
Copying Andrew Tsai's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -30.80% per trade.
2 Years
xxx
Success Rate
0/4 ratings generated profit
Average Return
-69.58%
upgraded a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -69.58% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
RLMD Analyst Recommendation Trends
Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
7
3
8
8
7
Sell
7
1
0
0
0
Strong Sell
0
0
0
0
0
total
14
4
8
8
7
Each month's total comprises the sum of three months' worth of ratings.
RLMD Stock Forecast FAQ
What is RLMD’s average 12-month price target, according to analysts?
Based on analyst ratings, Relmada Therapeutics’s 12-month average price target is 1.00.
What is RLMD’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for RLMD, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is RLMD a Buy, Sell or Hold?
Relmada Therapeutics has a consensus rating of Hold which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Relmada Therapeutics’s price target?
The average price target for Relmada Therapeutics is 1.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $1.00 ,the lowest forecast is $1.00. The average price target represents -39.76% Decrease from the current price of $1.66.
The highest analyst price target is $1.00 ,the lowest forecast is $1.00. The average price target represents -39.76% Decrease from the current price of $1.66.
What do analysts say about Relmada Therapeutics?
Relmada Therapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of RLMD?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.